FORWARD PHARMA A/S
Core data
Name | FORWARD PHARMA A/S |
Address | Strandvejen 125, 2900, Hellerup |
Founded | Jul 1, 2005 |
Employees (CVR) | 2 |
Locations (P-units) | 0 |
Website | www.forward-pharma.com |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Name | FORWARD PHARMA A/S |
Address | Strandvejen 125, 2900, Hellerup |
Founded | Jul 1, 2005 |
Employees (CVR) | 2 |
Locations (P-units) | 0 |
Website | www.forward-pharma.com |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Keep track of FORWARD PHARMA A/S
Financials
| Reporting period | ||||||||
|---|---|---|---|---|---|---|---|---|
| Gross profit | -9,457,909 | |||||||
| Operating profit | -11,296,036 | |||||||
| Profit before tax | -9,931,573 | |||||||
| Net income | 75,927,645 | |||||||
| Total assets | 835,352,476 | |||||||
| Equity | 488,330,233 | |||||||
| Avg. employees | 2 | |||||||
2017–2024 Unlock financial history | ||||||||
Datapublica Risk Score
What goes into the assessment
Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details
Standard: Score and risk bandPro: Also a detailed explanation of the factors
Gazelle
Loading gazelle status…
Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.
People
No current people or role data available
Auditor
| Audit firm | Auditor | Role | From |
|---|---|---|---|
| PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab | AuditorBo Schou-Jacobsen | RoleState Authorised Public Accountant | FromMay 16, 2025 |
| — | AuditorChristian Bo Gjelstrup Pedersen | RoleState Authorised Public Accountant | FromMay 16, 2025 |
Legal owners
| Owner | Ownership | Voting rights | From | To |
|---|---|---|---|---|
Foreign legal entity | Ownership5–9.99 % | Voting rights5 % | FromOct 30, 2024 | ToNov 26, 2025 |
| Ownership5–9.99 % | Voting rights5 % | FromSep 23, 2024 | ToNov 26, 2025 | |
Unknown Other Participant | Ownership5–9.99 % | Voting rights5 % | FromAug 4, 2024 | ToNov 26, 2025 |
| Ownership20–24.99 % | Voting rights20 % | FromJun 12, 2024 | ToNov 26, 2025 | |
| Ownership20–24.99 % | Voting rights20 % | FromJun 12, 2024 | ToNov 26, 2025 | |
Unknown Other Participant | Ownership10–14.99 % | Voting rights10 % | FromMay 31, 2024 | ToOct 30, 2024 |
Foreign legal entity | Ownership5–9.99 % | Voting rights5 % | FromAug 4, 2024 | ToSep 23, 2024 |
Foreign legal entity | Ownership10–14.99 % | Voting rights10 % | FromJun 12, 2024 | ToAug 3, 2024 |
Foreign legal entity | Ownership90–99.99 % | Voting rights90 % | FromMar 11, 2022 | ToJun 11, 2024 |
| Ownership20–24.99 % | Voting rights20 % | FromNov 14, 2014 | ToMar 11, 2022 | |
Unknown Other Participant | Ownership20–24.99 % | Voting rights20 % | FromNov 14, 2014 | ToMar 11, 2022 |
| Ownership20–24.99 % | Voting rights20 % | FromOct 14, 2014 | ToMar 11, 2022 | |
Unknown Other Participant | Ownership15–19.99 % | Voting rights15 % | FromOct 14, 2014 | ToMar 11, 2022 |
| Ownership5–9.99 % | Voting rights5 % | FromOct 14, 2014 | ToMar 11, 2022 |
Child companies
| Company | Ownership | Voting rights | From | To |
|---|---|---|---|---|
| Ownership100 % | Voting rights100 % | FromJun 30, 2017 | ToOct 30, 2025 | |
| Ownership100 % | Voting rights100 % | FromDec 3, 2015 | ToJun 30, 2017 |